GlaxoSmithKline | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2009 | KY-AG | $661,860 |
Janssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | False Claims Act and related | 2012 | KY-AG | $7,000,000 |
Merck Sharp & Dohme Corp. | Merck | False Claims Act and related | 2012 | KY-AG | $6,000,000 |
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. | Viatris | False Claims Act and related | 2011 | KY-AG | $6,500,000 |
Novartis Pharmaceuticals Corp. | Novartis | False Claims Act and related | 2012 | KY-AG | $2,750,000 |
Par Pharmaceutical Inc. | Endo International | False Claims Act and related | 2011 | KY-AG | $4,500,000 |
Purdue Pharma | Purdue Pharma | drug or medical equipment safety violation | 2015 | KY-AG | $24,000,000 |
Sandoz | Sandoz Group | False Claims Act and related | 2009 | KY-AG | $16,000,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | kickbacks and bribery | 2006 | KY-AG | $600,000 |
Teva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | KY-AG | $10,000,000 |
Ethicon | Johnson & Johnson | consumer protection violation | 2023 | KY-AG | $9,900,000 |
Teva Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | consumer protection violation | 2023 | KY-AG | $1,407,000 |
Teva Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2023 | KY-AG | $71,477,474 |
Allergan PLC | AbbVie | off-label or unapproved promotion of medical products | 2023 | KY-AG | $48,666,145 |
Abbott Laboratories | AbbVie | False Claims Act and related | 2013 | LA-AG | $6,200,000 |
Actavis | AbbVie | False Claims Act and related | 2012 | LA-AG | $4,000,000 |
Apotex | Apotex Corp. | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
Astellas | Astellas Pharma | False Claims Act and related | 2013 | LA-AG | $1,130,000 |
Aventis | Sanofi | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Biovail | Bausch Health | False Claims Act and related | 2013 | LA-AG | $200,000 |
Boehringer Ingelheim | Boehringer Ingelheim | False Claims Act and related | 2012 | LA-AG | $3,250,000 |
Dey | Viatris | False Claims Act and related | 2012 | LA-AG | $3,000,000 |
Eisai | Eisai | False Claims Act and related | 2013 | LA-AG | $1,000,000 |
Eli Lilly | Eli Lilly | False Claims Act and related | 2013 | LA-AG | $1,650,000 |
Eli Lilly | Eli Lilly | off-label or unapproved promotion of medical products | 2010 | LA-AG | $20,000,000 |
Forest Laboratories | AbbVie | False Claims Act and related | 2013 | LA-AG | $3,000,000 |
Gilead Sciences | Gilead Sciences | False Claims Act and related | 2013 | LA-AG | $250,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
Johnson & Johnson | Johnson & Johnson | False Claims Act and related | 2013 | LA-AG | $10,000,000 |
Lupin Pharmaceuticals | Lupin Limited | False Claims Act and related | 2013 | LA-AG | $750,000 |
Novartis | Novartis | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Par Pharmaceutical | Endo International | False Claims Act and related | 2013 | LA-AG | $6,000,000 |
Pernix Therapeutics | Currax Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $800,000 |
Perrigo | Perrigo | False Claims Act and related | 2013 | LA-AG | $2,000,000 |
Ranbaxy | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Sandoz | Sandoz Group | False Claims Act and related | 2013 | LA-AG | $13,100,000 |
Schering-Plough | Merck | False Claims Act and related | 2012 | LA-AG | $5,000,000 |
Shire | Takeda Pharmaceutical | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
Takeda/Tap Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2013 | LA-AG | $3,750,000 |
Taro Pharmaceutical Industries | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
UCB | UCB | False Claims Act and related | 2013 | LA-AG | $3,350,000 |
General Nutrition Corporation | Harbin Pharmaceutical Group | wage and hour violation | 2017 | MA-AG | $72,304 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MA-AG | $3,600,000 |
Amphastar Pharmaceuticals, Inc. | Amphastar Pharmaceuticals | price-fixing or anti-competitive practices | 2015 | MA-AG | $325,000 |
Barr Laboratories, Inc. and Duramed Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2007 | MA-AG | $2,000,000 |
Boehringer Ingelheim Roxane, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2008 | MA-AG | $1,800,000 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Dey, Inc. | Viatris | False Claims Act and related | 2007 | MA-AG | $2,900,000 |
Eisai Co. | Eisai | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Hoffman-LaRoche | Roche | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Janssen Pharmaceuticals, Inc. | Johnson & Johnson | off-label or unapproved promotion of medical products | 2013 | MA-AG | $15,100,000 |
Merck & Co., Inc. | Merck | False Claims Act and related | 2011 | MA-AG | $24,000,000 |
Mylan Inc. | Viatris | False Claims Act and related | 2010 | MA-AG | $2,600,000 |
Mylan Specialty, L.P. | Viatris | off-label or unapproved promotion of medical products | 2013 | MA-AG | $250,000 |
Par Pharmaceutical, Inc. | Endo International | False Claims Act and related | 2010 | MA-AG | $500,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2013 | MA-AG | $375,000 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Teva Pharmaceutical USA, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | MA-AG | $7,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MA-AG | $2,400,000 |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | environmental violation | 2021 | MA-AG | $600,000 |
AMGEN INC | Amgen | environmental violation | 2006 | MA-ENV | $11,600 |
ANIKA THERAPEUTICS INC | Anika Therapeutics | environmental violation | 2003 | MA-ENV | $15,500 |
AMGEN INC | Amgen | environmental violation | 2002 | MA-ENV | $15,000 |
BRISTOL-MYERS SQUIBB | Bristol-Myers Squibb | environmental violation | 2023 | MA-ENV | $11,615 |
GlaxoSmithKline, LLC | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2013 | MD-AG | $15,000,000 |
Teva | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2024 | MD-AG | $70,281,867 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2024 | MD-AG | $38,166,450 |
ZOETIS LLC | Zoetis | environmental violation | 2019 | MI-ENV | $14,625 |
Allergan Inc | AbbVie | wage and hour violation | 2019 | MI-LEO | $7,656 |
Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | wage and hour violation | 2018 | MI-LEO | $12,500 |
Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | wage and hour violation | 2018 | MI-LEO | $5,070 |
Allergan Usa Inc | AbbVie | wage and hour violation | 2017 | MI-LEO | $64,828 |
Allergan Plc | AbbVie | wage and hour violation | 2016 | MI-LEO | $73,999 |
Allergan Usa Inc | AbbVie | wage and hour violation | 2016 | MI-LEO | $73,999 |
Novartis Pharmaceuticals Corporation | Novartis | wage and hour violation | 2014 | MI-LEO | $13,000 |
Novartis Pharmaceuticals Corporation | Novartis | wage and hour violation | 2014 | MI-LEO | $5,885 |
Dey Inc. | Viatris | False Claims Act and related | 2006 | MO-AG | $2,932,000 |
Roxane, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2010 | MO-AG | $3,100,000 |
Schering-Plough | Merck | False Claims Act and related | 2008 | MO-AG | $31,000,000 |
Teva Pharmaceuticals USA | Teva Pharmaceutical Industries | environmental violation | 2013 | MO-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,402,793 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | environmental violation | 2003 | MO-AG | $70,000 |
Mallinckrodt/Covidien | Mallinckrodt | environmental violation | 2011 | MO-ENV | $6,000 |
Alere Inc. | Abbott Laboratories | kickbacks and bribery | 2017 | MS-AG | $2,000,000 |
Alpharma USPD, Inc., | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Dey Labs | Viatris | False Claims Act and related | 2009 | MS-AG | $3,900,000 |
Eli Lilly | Eli Lilly | off-label or unapproved promotion of medical products | 2010 | MS-AG | $18,500,000 |
Par Pharmaceutical Co. | Endo International | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Purepac Pharmaceutical Co., n/k/a Actavis Elizabeth, LLC | Pfizer | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Sandoz, Inc. | Sandoz Group | False Claims Act and related | 2011 | MS-AG | $30,110,618 |
Watson, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2018 | MS-AG | $33,408,547 |
Dey LP | Viatris | False Claims Act and related | 2007 | MT-AG | $198,000 |
Janssen Ortho LLC and Janssen Pharmaceuticals, Inc. | Johnson & Johnson | off-label or unapproved promotion of medical products | 2014 | MT-AG | $5,900,000 |
Abbott Laboratories | Abbott Laboratories | False Claims Act and related | 2003 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $32,500,000 |
Abbott Laboratories | AbbVie | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $339,148,643 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $22,500,000 |
AbbVie Inc. | AbbVie | kickbacks and bribery | 2018 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,800,000 |
Aegerion Pharmaceuticals Inc. | Amryt Pharma | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,700,000 |
Alere Inc. | Abbott Laboratories | False Claims Act and related | 2018 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,860,779 |
Allergan Inc. | AbbVie | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $14,750,000 |
Alpharma Inc. | Pfizer | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $8,900,000 |